Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH. Cassataro J, et al. Infect Immun. 2005 Dec;73(12):8079-88. doi: 10.1128/IAI.73.12.8079-8088.2005. Infect Immun. 2005. PMID: 16299302 Free PMC article.
A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA. Cassataro J, et al. Vaccine. 2007 May 30;25(22):4437-46. doi: 10.1016/j.vaccine.2007.03.028. Epub 2007 Apr 2. Vaccine. 2007. PMID: 17442465
A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination.
Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Zwerdling A, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA. Cassataro J, et al. Vaccine. 2007 Aug 10;25(32):5958-67. doi: 10.1016/j.vaccine.2007.05.049. Epub 2007 Jun 12. Vaccine. 2007. PMID: 17600596
Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.
Barrionuevo P, Cassataro J, Delpino MV, Zwerdling A, Pasquevich KA, García Samartino C, Wallach JC, Fossati CA, Giambartolomei GH. Barrionuevo P, et al. Among authors: cassataro j. Infect Immun. 2008 Jan;76(1):250-62. doi: 10.1128/IAI.00949-07. Epub 2007 Nov 5. Infect Immun. 2008. PMID: 17984211 Free PMC article.
Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus.
Zwerdling A, Delpino MV, Barrionuevo P, Cassataro J, Pasquevich KA, García Samartino C, Fossati CA, Giambartolomei GH. Zwerdling A, et al. Among authors: cassataro j. Microbes Infect. 2008 Oct;10(12-13):1346-54. doi: 10.1016/j.micinf.2008.07.035. Epub 2008 Aug 12. Microbes Infect. 2008. PMID: 18761420 Free article.
Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J. Pasquevich KA, et al. Among authors: cassataro j. Infect Immun. 2009 Jan;77(1):436-45. doi: 10.1128/IAI.01151-08. Epub 2008 Nov 3. Infect Immun. 2009. PMID: 18981242 Free PMC article.
64 results